Os desafios e dificuldades enfrentadas por portadores de hanseníase durante a pandemia da COVID-19
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Identificar os desafios enfrentados por pacientes hansênicos durante a pandemia da COVID-19. Métodos: O estudo é uma revisão integrativa, para o qual foi realizado um levantamento dos artigos nas bases de dados Biblioteca Virtual em Saúde (BVS) e PubMed. Os descritores e a combinação utilizada foi: (HANSENÍASE) AND (COVID-19), (HANSENÍASE) AND (COVD-19) AND (PANDEMIA), (HANSENÍASE) AND (PANDEMIA), (LEPROSY) AND (COVID-19), (LEPROSY) AND (PANDEMIC), (LEPROSY) AND (COVID-19) AND (PANDEMIC). Incluíu-se os artigos que discutiam sobre a Hanseníase e o desfecho da doença na população durante o período pandêmico, de forma gratuita, em todos os idiomas, publicados a partir do início da disseminação da COVID-19, de 2019 a 2022. Resultados: Houve remanejamento do sistema de saúde para tentar conter o avanço da infecção por SARS-CoV-2. Tal fato levou à diminuição de profissionais disponíveis para os setores de hanseníase nas unidades de saúde, a carência de medicamentos, diagnóstico deficiente e problemas psicológicos aos indivíduos, havendo a subnotificação de casos em vários locais, como o Brasil. Conclusão: Sugere-se a capacitação profissional sobre o manejo de pacientes hansênicos e a utilização desse estudo para traçar planos que visem a melhoria programas de saúde pública para que não sejam afetados gravemente com fatores externos.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
2. ANTUNES DE, et al. Will cases of leprosy reaction increase with COVID-19 infection? PLoS neglected tropical diseases, 2020; 14(7): 0008460.
3. APONSO S, et al. Multibacillary leprosy unmasked by COVID-19 vaccination. JAAD Case Reports. 2022; 19: 87-89.
4. ARORA S, et al. Hansen's disease in the era of COVID‐19: An observation on a series of six patients with co‐infection. Dermatologic Therapy, 2021; 34(2): 4827.
5. BHARDWAJ A, et al. Updates on Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by IADVL SIG Leprosy. Indian Dermatol Online Journal. 2021; 12(1): S24-S30.
6. BRASIL. Ministério da Saúde. Gabinete do Ministro. Painel Coronavírus. Brasília, 2022.
7. CÁCERES-DURÁN MÁ. Comportamiento epidemiológico de lá lepra en vários países de América Latina, 2011-2020. Revista Panamericana de Salud Pública. 2022; 46: 14.
8. CAVALIERO A e QUAO B. GPZL working group assesses challenges and a path forward for leprosy during COVID-19. Leprosy Review, 2020; 91(4): 421-424.
9. CERQUEIRA SRPS, et al. The influence of leprosy-related clinical and epidemiological variables on the occurrence and severity of COVID-19: a prospective real-world cohort study. PLoS neglected tropical diseases, 2021; 15(7): 0009635.
10. DA PAZ WS, et al. Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study. Lancet Regional Health-Americas. 2022; 9: 100181.
11. DA CUNHA VP, et al. Application of the ARIMA Model to Predict Under-Reporting of New Cases of Hansen’s Disease during the COVID-19 Pandemic in a Municipality of the Amazon Region. International Journal of Environmental Research and Public Health, 2021; 19(1): 415.
12. DE ARAÚJO SANTOS GC, et al. COVID-19 and the incidence of neglected tropical diseases: reflections in times of pandemic. ABCS Health Sciences, 2021; 46: 021102-021102.
13. DE BARROS B, et al. An assessment of the reported impact of the COVID-19 pandemic on leprosy services using an online survey of practitioners in leprosy referral centres. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2021; 115(12): 1456-1461.
14. DEPS P, et al. Hansen's disease case detection in Brazil: a backlog of undiagnosed cases due to COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology, 2022; 36(10): 754-755.
15. DOMINIC S, et al. Impact of Lockdown Restrictions on Treatment of Leprosy: A Retrospective Analysis. Indian Dermatol Online Journal. 2022; 13(3): 370-374.
16. FAUZIYAH S, et al. How should Indonesia consider its neglected tropical diseases in the COVID-19 era? Hopes and challenges. Biomedical reports. 2021; 14(6): 1-10.
17. FORMIGOSA e C de AC, et al. Impact of COVID-19 pandemic on notifiable diseases in Northern Brazil. Revista Brasileira em Promoção da Saúde, 2022; 35: 1-11.
18. GÓMEZ ECHEVARRÍA JR et aç. Lepra, coronavirus, estigmatización. Revista de leprologia Fontilles, 2020; 23 (6): 393-394.
19. HANAMANTHU V, et al. Comment on "Multibacillary leprosy unmasked by COVID-19 vaccination". JAAD Case Reports. 2022; 26: 1-2.
20. KURIZKY PS, et al. The challenge of concomitant infections in the coronavirus disease 2019 pandemic era: Severe acute respiratory syndrome coronavirus 2 infection in a patient with chronic Chagas disease and dimorphic leprosy. Revista da Sociedade Brasileira de Medicina Tropical. 2020; 53: 20200504.
21. LIMA LV, et al. Temporal trend, distribution and spatial autocorrelation of leprosy in Brazil: ecological study, 2011 to 2021. Revista Brasileira de Epidemiologia, 2022; 5(25): 220040.
22. MAHATO S, et al. Inequities towards leprosy-affected people: A challenge during COVID-19 pandemic. PLoS neglected tropical diseases, 2020; 14(7): 0008537.
23. MARQUES NP, et al. Impact of the coronavirus disease 2019 on the diagnoses of Hansen's disease in Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 2021; 54: 0251.
24. MATOS TS, et al. Impact of the COVID-19 pandemic on the diagnosis of new leprosy cases in Northeastern Brazil, 2020. International journal of dermatology, 2021; 60(8): 1003-1006.
25. MENDONÇA IMS, et al. Impact of the COVID-19 pandemic on care for patients with leprosy: an evaluative study from the perspective of health professionals. Pesquisa, Sociedade e Desenvolvimento, 2022; 11(2): 4111225459-4111225459.
26. MONDIALE DE LA SANTÉ O, et al. Global leprosy (Hansen disease) update, 2020: impact of COVID-19 on global leprosy control. Relevé épidémiologique hebdomadaire, 2021; 95(36):e417-438.
27. PINTO F de M, et al. LEPROSY: A LITERATURE REVIEW. 2015.
28. RATHOD S, et al. Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by SIG Leprosy (IADVL Academy). Indian Dermatol Online Journal. 2020; 11(3): 345-348.
29. REPSOLD TAR, et al. Hansen’s disease and COVID-19 co-infection in Brazil. International Journal of Dermatology, 2022; 6: 1506-1510.
30. SANTOS VS, et al. Clinical characteristics and outcomes in patients with COVID-19 and leprosy. Journal of the European Academy of Dermatology and Venereology, 2021; 35(1): 1-2.
31. TUCKER A, et al. Persons affected by leprosy and the COVID-19 global health crisis: a consultative calls report from GPZL’s emergency response working group 2. Leprosy Review, 2020; 91(4): 425-430.
32. VAN DOREMALEN, N et al. Aerosol and surface stability of SARS-CoV-2 compared to SARS-CoV-19. New England Journal off medicine, 2020; 382(16): 1564-1567.
33. XAVIER AR, et al. COVID-19: clinical and laboratory manifestations in the infection by the new coronavirus. Jornal Brasileiro de Patologia e Medicina Laboratorial, 2020; 56.
34. ZIEMBOWICZ H, et al. The consequences Sars-CoV-2 pandemic on medical education in the combat leprosy. Revista de Epidemiologia e Controle de Infecção, 2022; 12(1): 7-12.